Unbiased screen for interactors of leucine-rich repeat kinase 2 supports a common pathway for sporadic and familial Parkinson disease

  • A Beilina
  • , IN Rudenko
  • , A Kaganovich
  • , L Civiero
  • , H Chau
  • , SK Kalia
  • , LV Kalia
  • , E Lobbestael
  • , R Chi
  • , K Ndukwe
  • , J Ding
  • , MA Nalls
  • , M Olszewski
  • , DN Hauser
  • , R Kumaran
  • , AM Lozano
  • , V Baekelandt
  • , LE Greene
  • , JM Taymans
  • , E Greggio
  • MR Cookson

Research output: Contribution to journalArticleAcademicpeer-review

312 Citations (Scopus)

Abstract

Mutations in leucine-rich repeat kinase 2 (LRRK2) cause inherited Parkinson disease (PD), and common variants around LRRK2 are a risk factor for sporadic PD. Using protein-protein interaction arrays, we identified BCL2-associated athanogene 5, Rab7L1 (RAB7, member RAS oncogene family-like 1), and Cyclin-G-associated kinase as binding partners of LRRK2. The latter two genes are candidate genes for risk for sporadic PD identified by genome-wide association studies. These proteins form a complex that promotes clearance of Golgi-derived vesicles through the autophagy-lysosome system both in vitro and in vivo. We propose that three different genes for PD have a common biological function. More generally, data integration from multiple unbiased screens can provide insight into human disease mechanisms.
Original languageUndefined/Unknown
Pages (from-to)2626-2631
Number of pages6
JournalProceedings of the National Academy of Sciences of the U.S.A.
Volume111
Issue number7
DOIs
Publication statusPublished - 2014
Externally publishedYes

Research programs

  • EMC NIHES-01-64-01

Cite this